These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 1395460)

  • 1. Blood glucose control and diabetic microvascular complications: long-term effects of near-normoglycaemia.
    Hanssen KF; Bangstad HJ; Brinchmann-Hansen O; Dahl-Jørgensen K
    Diabet Med; 1992 Oct; 9(8):697-705. PubMed ID: 1395460
    [No Abstract]   [Full Text] [Related]  

  • 2. Lessons from the Diabetes Control and Complications Trial.
    Santiago JV
    Diabetes; 1993 Nov; 42(11):1549-54. PubMed ID: 8405693
    [No Abstract]   [Full Text] [Related]  

  • 3. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study.
    Ohkubo Y; Kishikawa H; Araki E; Miyata T; Isami S; Motoyoshi S; Kojima Y; Furuyoshi N; Shichiri M
    Diabetes Res Clin Pract; 1995 May; 28(2):103-17. PubMed ID: 7587918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microvascular complications: pathophysiology and management.
    Vithian K; Hurel S
    Clin Med (Lond); 2010 Oct; 10(5):505-9. PubMed ID: 21117389
    [No Abstract]   [Full Text] [Related]  

  • 5. Diabetic control and microvascular complications: the near-normoglycaemic experience.
    Hanssen KF; Dahl-Jørgensen K; Lauritzen T; Feldt-Rasmussen B; Brinchmann-Hansen O; Deckert T
    Diabetologia; 1986 Oct; 29(10):677-84. PubMed ID: 3542669
    [No Abstract]   [Full Text] [Related]  

  • 6. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial.
    Diabetes; 1995 Aug; 44(8):968-83. PubMed ID: 7622004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ISPAD Clinical Practice Consensus Guidelines 2014. Microvascular and macrovascular complications in children and adolescents.
    Donaghue KC; Wadwa RP; Dimeglio LA; Wong TY; Chiarelli F; Marcovecchio ML; Salem M; Raza J; Hofman PL; Craig ME;
    Pediatr Diabetes; 2014 Sep; 15 Suppl 20():257-69. PubMed ID: 25182318
    [No Abstract]   [Full Text] [Related]  

  • 8. Increasing severity of cardiac autonomic neuropathy is associated with increasing prevalence of nephropathy, retinopathy, and peripheral neuropathy in Turkish type 2 diabetics.
    Bilal N; Erdogan M; Ozbek M; Cetinkalp S; Karadeniz M; Ozgen AG; Saygili F; Yilmaz C; Tüzün M; Kabalak T
    J Diabetes Complications; 2008; 22(3):181-5. PubMed ID: 18413163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implications of the Diabetes Control and Complications Trial. American Diabetes Association.
    Diabetes; 1993 Nov; 42(11):1555-8. PubMed ID: 8405694
    [No Abstract]   [Full Text] [Related]  

  • 10. Blood glucose control and microvascular complications--what do we do now?
    Dahl-Jørgensen K; Brinchmann-Hansen O; Bangstad HJ; Hanssen KF
    Diabetologia; 1994 Dec; 37(12):1172-7. PubMed ID: 7895945
    [No Abstract]   [Full Text] [Related]  

  • 11. [Late complications of diabetes--can we prevent them?].
    Kappeler H
    Schweiz Rundsch Med Prax; 1988 Mar; 77(9):222-9. PubMed ID: 3363266
    [No Abstract]   [Full Text] [Related]  

  • 12. Occurrence and interrelationships of complications in insulin-dependent diabetes in Finland.
    Ebeling P; Koivisto VA
    Acta Diabetol; 1997 Mar; 34(1):33-8. PubMed ID: 9134055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetic complications. The importance of glucose control.
    Skyler JS
    Endocrinol Metab Clin North Am; 1996 Jun; 25(2):243-54. PubMed ID: 8799699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of microvascular complications in diabetic children and adolescents.
    Verrotti A; Catino M; Di Ricco L; Casani A; Chiarelli F
    Acta Paediatr Suppl; 1999 Jan; 88(427):35-8. PubMed ID: 10195852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The case for blood glucose control.
    Genuth SM
    Adv Intern Med; 1995; 40():573-623. PubMed ID: 7747658
    [No Abstract]   [Full Text] [Related]  

  • 16. DCCT: implications for diabetes care in the UK.
    Boulton AJ
    Diabet Med; 1993 Oct; 10(8):687. PubMed ID: 8261748
    [No Abstract]   [Full Text] [Related]  

  • 17. [Maillard reaction products and chronic diabetic complications].
    Trivin F; Chevenne D; Hautecouverture M
    Ann Biol Clin (Paris); 1999; 57(4):445-54. PubMed ID: 10432367
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical review 51: Implications of the Diabetes Control and Complications Trial.
    Eastman RC; Siebert CW; Harris M; Gorden P
    J Clin Endocrinol Metab; 1993 Nov; 77(5):1105-7. PubMed ID: 8077299
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus.
    Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group
    JAMA; 2002 May; 287(19):2563-9. PubMed ID: 12020338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microvascular Complications of Type 2 Diabetes Mellitus.
    Faselis C; Katsimardou A; Imprialos K; Deligkaris P; Kallistratos M; Dimitriadis K
    Curr Vasc Pharmacol; 2020; 18(2):117-124. PubMed ID: 31057114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.